Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Jose Carlos Tapia"'
Autor:
Mimma Rizzo, Andrey Soares, Enrique Grande, Aristotelis Bamias, Ray Manneh Kopp, Edoardo Lenci, Thomas Buttner, Samer Salah, Francesco Grillone, Icaro Thiago de Carvalho, Jose Carlos Tapia, Calogero Gucciardino, Alvaro Pinto, Alessia Mennitto, Halima Abahssain, Pasquale Rescigno, Zin Myint, Hideki Takeshita, Gian Paolo Spinelli, Lazar Popovic, Maria Giuseppa Vitale, Ondrej Fiala, Patrizia Giannatempo, Roubini Zakopoulou, Francesco Carrozza, Francesco Massari, Fernando Sabino Marques Monteiro, Maria Paola Pace, Massimo Giannini, Giandomenico Roviello, Camillo Porta, Nicola Battelli, Ravindran Kanesvaran, Matteo Santoni
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The addition of metastasis-directed radiotherapy (MDRT) to immunotherapy in patients with advanced urothelial carcinoma (aUC) has shown promising results. We report the real-world data from the ARON-2 study (NCT05290038) on the impact of con
Externí odkaz:
https://doaj.org/article/7c7f88d7c9824bbc938bd6730c370b0e
Autor:
Consolacion Molto, Ariadna Tibau, Aida Bujosa, Jose Carlos Tapia, Abhenil Mittal, Faris Tamimi, Eitan Amir
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Little is known about the impact of control group therapy on clinical benefit scales such as American Society of Clinical Oncology Value Framework (ASCO-VF), European Society for Medical Oncology Magnitude Clinical Benefit Scale (ESMO-MCBS),
Externí odkaz:
https://doaj.org/article/4fa9188644864211aa9665663302eecc
Autor:
Maria Lazo-Porras, Gabriela J. Prutsky, Patricia Barrionuevo, Jose Carlos Tapia, Cesar Ugarte-Gil, Oscar J. Ponce, Ana Acuña-Villaorduña, Juan Pablo Domecq, Celso De la Cruz-Luque, Larry J. Prokop, Germán Málaga
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background To evaluate the effectiveness and safety of the World Health Organization antibiotic regimen for the treatment of paucibacillary (PB) and multibacillary (MB) leprosy compared to other available regimens. Methods We performed a sea
Externí odkaz:
https://doaj.org/article/5a67d8905394407991036a0cc217ad80
Autor:
José María Tapia-González, Tomás Martínez- Serratos, José Octavio Macias-Macias, Francisca Contreras-Escareño, Ma. Patricia Rivera-Espinoza, Enrique Rodríguez-López, Jose Carlos Tapia-Rivera
Publikováno v:
Ecosistemas y Recursos Agropecuarios, Vol 8, Iss 2 (2021)
El objetivo de estudio fue relacionar la producción de miel de las colonias de Apis mellífera seleccionadas con parámetros geográficoambientales del sur de Jalisco. Se midió la producción de miel de 9 169 colonias, se seleccionaron 352, las que
Externí odkaz:
https://doaj.org/article/d058c344cc1748c1b9e61f8a83433151
Autor:
Jose Maria Tapia-Gonzalez, Gustavo Alcazar-Oceguera, José Octavio Macías-Macías, Francisca Contreras-Escareño, Jose Carlos Tapia-Rivera, Tatiana Petukhova, Ernesto Guzman-Novoa
Publikováno v:
Ecosistemas y Recursos Agropecuarios, Vol 6, Iss 17 (2019)
El objetivo fue determinar la prevalencia de Varroa destructor, el grado de infestación del ácaro y la relación del parásito con variables geográficas y climáticas en 369 colonias de abejas Apis mellifera de nueve municipios de zonas templadas
Externí odkaz:
https://doaj.org/article/25257af790ed43e786693f5a32f60b2c
Publikováno v:
F1000Research, Vol 5 (2016)
In 2004, an influential report in The Lancet suggested that open health information for all could be achieved by 2015. Unfortunately, this goal has not yet been accomplished. Despite progress in obtaining quality scientific articles in Latin America,
Externí odkaz:
https://doaj.org/article/31a0a3014123440bb3e014ee722125a7
Publikováno v:
F1000Research, Vol 5 (2016)
In 2004, an influential report in The Lancet suggested that open health information for all could be achieved by 2015. Unfortunately, this goal has not yet been accomplished. Despite progress in obtaining quality scientific articles in Latin America,
Externí odkaz:
https://doaj.org/article/b61b867bbcf94cb9b0aea2fe4d1d0d78
Autor:
Jose Carlos Tapia, Thomas J Hwang, Arnoud J. Templeton, Ariadna Tibau, Agustí Barnadas, Aida Bujosa, Kerstin Noëlle Vokinger, Consolación Molto, Ignasi Gich, Eitan Amir
Publikováno v:
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Most anticancer drugs are approved by regulatory agencies based on surrogate measures. This article explores the variables associated with overall survival (OS), quality of life (QoL), and substantial clinical benefit among anticancer dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9f29600a4b3248ec0f07837e849590
https://www.zora.uzh.ch/id/eprint/217219/
https://www.zora.uzh.ch/id/eprint/217219/
Autor:
Elia Seguí, Edouard Auclin, Juan Manuel Torres, David Casadevall, Juan Aguilar-Company, Marta Rodríguez, Nicolas Epaillard, Javier Gavira, Jose Carlos Tapia, Marco Tagliamento, Sara Pilotto, Rafael Lopez, Xabier Mielgo, Juan Bautista Blaquier, María Bluthgen, Jose Nicolas Minatta, Cristina Urbano, Aleix Prat, Alexandru Vlagea, Laura Mezquita
Publikováno v:
Journal of Clinical Oncology. 40:2551-2551
2551 Background: Inflammation and neutrophils play a central role in severe Covid-19 disease. In previous data, we showed that the FLARE score, combining both tumor and Covid-19-induced proinflammatory status (proinflam-status), predicts early mortal
Autor:
Laia Llobera Rius, Silvia Martin Batista, Kevin Molina-Mata, Miguel Sagüés, Susana Vives, Cristian Tebe Cordomi, Miriam Moreno, Anna Sureda Balari, Alberto Mussetti, Margarita Majem Tarruella, Roser Fort Culillas, Javier Gavira Diaz, Felip Falgas, Rosa Coll, Ramon Salazar, Juan Jimenez, Maria Condom, Clara Maluquer, Lucia Llavata Martí, Jose Carlos Tapia, Ali Bazarbachi, Carme Talarn
Publikováno v:
Blood
Introduction Coronavirus Disease 2019 (COVID19) has shown higher mortality in patients with comorbidities, including cancer. First reports from China, Italy, and US showed mortality comprised between 20% and 40% in this specific population. However,